(Circulation. 2001;104:1040.)
© 2001 American Heart Association, Inc.
Basic Science Reports |
From the Vascular Biology Unit, Whitaker Cardiovascular Institute, Boston University Medical Center, Boston, Mass.
Correspondence to Richard A. Cohen, MD, Director, Vascular Biology Unit, Boston Medical Center X708, 650 Albany St, Boston, MA 02118. E-mail racohen{at}bu.edu
| Abstract |
|---|
|
|
|---|
Methods and Results A selective guanylyl cyclase inhibitor, 1H-[1,2,4]-oxadiazole-[4,3-a]quinoxalin-1-one, eliminated SNP-induced relaxation but only partially blocked NO-induced relaxation in both normal and HC aorta. The residual relaxation to NO was still less in HC and, in both normal and HC aorta, was abolished by concomitant administration of the SERCA inhibitor cyclopiazonic acid (CPA). In contrast, CPA did not affect SNP-induced relaxation in either normal or HC aorta. SERCA activity measured by 45Ca2+ uptake was markedly decreased in HC, although SERCA2 protein expression did not change significantly.
Conclusions These data suggest that NO-induced relaxation but not that to SNP is partially mediated by cGMP-independent Ca2+ uptake into sarco/endoplasmic reticulum and that reduced sarco/endoplasmic reticulum Ca2+ pump function can account for the impaired response to NO in HC.
Key Words: hypercholesterolemia nitric oxide sarcoplasmic reticulum muscle, smooth calcium
| Introduction |
|---|
|
|
|---|
NO gas requires diffusion, which can be interfered with by oxygen, superoxide anion, and metals.4 SNP can release NO by 1 electron reduction at the plasma membrane of smooth muscle cells,5 where it might not be as susceptible as NO to scavenging. HC increases superoxide production,6 and therefore increased scavenging of NO might account for the discrepancy between NO and SNP. Although long-term treatment with antioxidants improves vascular function in HC rabbit aorta, antioxidants like glutathione ester7 or other scavengers of superoxide anion do not immediately normalize responses either to endothelium-dependent agents or to NO. Adenoviral transfection of superoxide dismutase (SOD) had no effect,8 and extended in vivo treatment with a cell-permeable form of SOD9 only partially improved endothelium-dependent relaxation in HC. In addition, the response to even high concentrations of NO is decreased in HC, even though these concentrations have been shown to effectively scavenge superoxide anion.10 Therefore, it is difficult to explain the reduced response in HC by only the increased scavenging of NO.
Another possible reason for the difference in response to NO and SNP is differences in signaling pathways in aortic smooth muscle. We recently provided evidence that a principal action of NO in normal vascular smooth muscle and platelets is a reduction of intracellular free Ca2+ levels that occurs by cGMP-dependent and cGMP-independent mechanisms.1113 We also proposed that NO can activate potassium channels14 and sarco/endoplasmic reticulum calcium ATPase (SERCA)12 by cGMP-independent means, and it may be that there are differences in the contributions of these proteins to the relaxation caused by NO and SNP. In HC rabbit carotid arteries, potassium channelmediated relaxation to NO is not impaired in smooth muscle from HC,15 and therefore decreased response of potassium channels may not explain the decreased response to NO.
With this background, this study tested the differences in signaling pathways used by NO and SNP to relax the normal and HC rabbit aorta. The results indicate that differences in the dependence of NO and SNP on guanylyl cyclase and SERCA can explain why relaxations to NO, but not SNP, are decreased in HC.
| Methods |
|---|
|
|
|---|
Isometric Tension Measurement
The detailed methods were previously reported.15 Rings from the midportion of the descending aorta were used for this study. In some rings, the endothelium was removed mechanically. Rings were mounted at optimal resting tension (6 g). Some rings without endothelium were incubated with either 1H-[1,2,4]-oxadiazole-[4,3-a]quinoxalin-1-one (ODQ: 10 µmol/L), cyclopiazonic acid (CPA: 20 µmol/L), or both for 1 hour. A saturated NO gas solution (Matheson) was prepared as described previously.1 Thereafter, rings were contracted by adding phenylephrine to cause a 40% to 50% maximal contraction and then relaxed by logarithmic increments of NO or half-logarithmic increments of SNP, 8-bromo-cGMP, or acetylcholine. To test the effect of superoxide scavengers on NO-induced relaxation in HC, HC rabbit aortic rings were preincubated with 150 U/mL SOD or 10 µmol/L EUK-8, a synthetic SOD/catalase mimetic, for 1 hour.
SERCA Activity by 45Ca2+ Uptake
SERCA activity was measured by 45Ca2+ uptake in a postnuclear supernatant fraction based on published methods.16 Approximately 1.5 cm of the aortic arch was homogenized in sucrose buffer (100:1 wt/vol, 0.34 mol/L sucrose, 1 mmol/L PMSF, 2 mmol/L dithiothreitol) with a sintered glass-on-glass homogenizer on ice. The homogenate was centrifuged at 4000 rpm for 2 minutes at 4°C, and the supernatant was assayed. To determine SERCA-dependent uptake, paired samples were treated with thapsigargin (10 µmol/L) and incubated at 37°C for 15 minutes before assay. Either thapsigargin (10 µmol/L) or CPA (20 µmol/L) inhibited most of calcium uptake in normal homogenate (94±1.0% by thapsigargin, 95±1.0% by CPA). 45Ca2+ uptake buffer (mmol/L: Tris-HCl 30 [pH 7.0], KCl 100, NaN3 5, MgCl2 6, EGTA 0.15, CaCl2 0.12, oxalate 10) was mixed with 1 µCi 45Ca2+ and 2 mmol/L ATP at 37°C. The reaction was started by adding 100 µL of protein (250 to 400 µg, total volume 500 µL). Aliquots of this mixture (100 µL) were filtered through Whatman GF/C glass filters at 10, 30, and 60 minutes. The filters were rinsed 2 times with 2.5 mL wash buffer (30 mmol/L imidazole, 250 mmol/L sucrose, 0.5 mmol/L EGTA). 45Ca2+ uptake is calculated by counting the radioactivity collected by the filters and standardized by protein concentration determined by the Bradford method. To avoid potential decay of enzyme activity that occurred on freezing and thawing, each assay was performed simultaneously on freshly obtained aorta from pairs of normal and HC rabbits.
Cell Culture and Intracellular Free Calcium Measurement
Methods for primary cell culture of rabbit aortic smooth muscle from normal and HC rabbits were previously reported.1 Cells on coverslips were loaded with fura 2 acetoxy-methyl ester in PSS and fluorescence was measured. Intracellular free calcium ([Ca2+]i) was monitored by the ratio of absorbance at 340/380 nm. Cells were stimulated with 0.1 µmol/L angiotensin II or 20 µmol/L CPA to elevate [Ca2+]i, and either 1 µmol/L NO or 10 µmol/L SNP was added when [Ca2+]i level reached an equilibrium after the peak rise caused by angiotensin II or CPA.1,12
Western Blot Analysis
The remaining rabbit aortic arch was homogenized in Tris-sucrose buffer with 1% Triton X-100 and protease inhibitors. After centrifugation at 14 000 rpm for 15 minutes at 4°C, the supernatant was mixed with Laemmli buffer and applied to 7.5% SDS-PAGE gels (10 µg protein/lane) for separation. Proteins were transferred to nitrocellulose paper, and the membrane was incubated with antiSERCA 2 (Affinity Bioreagents, clone IID8, 1:2500, overnight) or
-actin (Sigma, 1:5000, 2 hours) antibody. The secondary anti-mouse IgG (Pierce, 1:50 000) was incubated, and bands were detected by enhanced chemiluminescence.
Statistical Analysis
Relaxations were analyzed by the maximum response after each concentration was added and were expressed as a percentage of the contraction to phenylephrine. Data are expressed as mean±SEM. Statistical evaluation of the concentration-response curves and the time course of Ca2+ uptake was performed with a repeated-measures ANOVA (SAS). The bands on Western blots were quantified by densitometry (Molecular Analyzer). Exponential half-time (
) was measured by estimating the rate of the initial decrease in [Ca2+]i caused by NO. Differences between groups of relaxation to individual concentrations of NO, exponential half-times, band densities, and SERCA activity were analyzed with Students t test. A value of P<0.05 was considered to be statistically significant.
| Results |
|---|
|
|
|---|
50% throughout a range of concentrations (ANOVA P<0.001, Figure 1C) but did not significantly change SNP-induced relaxation (Figure 1B).
|
Incubation of HC aorta for 1 hour with SOD or EUK-8 had no effect on NO-induced relaxation (Figure 1D).
A guanylyl cyclase inhibitor, ODQ (10 µmol/L), only partially inhibited NO-induced relaxation in both normal and HC arteries (Figure 2A). This concentration of ODQ completely blocked the rise in cGMP by either NO or SNP in normal arteries (Reference 11 and unpublished observations). The residual cGMP-independent relaxation to NO was also significantly decreased in HC (Figure 2A). Conversely, SNP-induced relaxation was nearly abolished by ODQ (Figure 2B), suggesting that SNP-induced relaxation is almost completely dependent on cGMP. Both SNP- and 8-bromo-cGMPinduced relaxation did not change in HC (Figure 2C), suggesting that cGMP-dependent relaxation is preserved in HC.
|
Previously, we reported that NO accelerated Ca2+ refilling into sarco/endoplasmic reticulum via SERCA. Therefore, we applied a SERCA inhibitor, CPA (20 µmol/L), and measured the relaxation to NO and SNP. CPA significantly inhibited NO-induced relaxation both in normal and to a smaller extent in HC aorta (Figure 3A). In contrast, CPA did not significantly alter SNP-induced relaxation in either normal or HC aorta, suggesting that SNP-induced relaxation does not depend on SERCA function (Figure 3B). CPA nearly abolished the ODQ-resistant relaxation up to 1 µmol/L NO in both normal and HC aorta (Figure 3C), suggesting that the cGMP-independent relaxation to NO is dependent on SERCA function.
|
Because these observations provided evidence that the contribution of SERCA to NO-induced relaxation is decreased in HC rabbit aorta, SERCA activity was measured directly in aortic homogenates by 45Ca2+ uptake. An irreversible SERCA inhibitor, thapsigargin, was applied in this assay to measure SERCA-dependent uptake. Thapsigargin-sensitive 45Ca2+ uptake was decreased significantly, from 20±2.2 to 10±2.7 nmol · mg-1 · min-1 (P=0.01, Figure 4A and 4B). Thapsigargin-insensitive 45Ca2+ uptake was not significantly different in normal and HC rabbit aortic homogenates (1.2±0.2 versus 2.1±0.7 nmol · mg-1 · min-1, P=0.24, Figure 4A), indicating that the change in thapsigargin-sensitive uptake reflects a specific difference in SERCA activity.
|
Figure 5A shows a typical recording of the decrease in [Ca2+]i caused by NO in cultured rabbit aortic smooth muscle from normal and HC rabbits. The rate of the decrease in [Ca2+]i caused by NO, represented by the exponential half-time, increased significantly, by 4-fold, in HC compared with normal smooth muscle (1.44±0.20 seconds, n=6, versus 5.93±1.69 seconds, n=7). Figure 5B shows the effect of ODQ and CPA on the decrease in [Ca2+]i to NO or SNP in normal rabbit aortic cells. ODQ almost completely abolished the response to 10 µmol/L SNP but had no significant effect on the response to 1 µmol/L NO. CPA blocked the decrease in [Ca2+]i caused by NO or SNP.
|
Because NO-induced relaxation, the decrease in [Ca2+]i, and 45Ca2+ uptake mediated by SERCA were reduced in HC rabbit aorta, the expression of SERCA protein was examined by Western blot (Figure 6A). Densitometry showed that the expression of SERCA 2 did not change significantly (8.0±0.5 U, n=5, versus 6.5±1.0 U, n=7, P=0.21). The expression of
-actin, another abundant smooth muscle protein, was also not significantly altered (13±1.7 U versus 14±2.0 U, P=0.84). The ratio of SERCA 2 to
-actin expression as detected by Western blot also did not significantly change in HC (0.7±0.2 versus 0.6±0.2, P=0.78, Figure 6B).
|
| Discussion |
|---|
|
|
|---|
In other studies, we have presented evidence that calcium uptake into intracellular stores by SERCA is normally involved in mediating the decrease in intracellular Ca2+ and relaxation of the aorta to NO and that the response is at least partially cGMP-independent.11,12 CPA reduced NO-induced relaxation in both normal and HC aorta, and the effects of thapsigargin were similar to those of CPA (unpublished observations). In contrast, SNP-induced relaxation was not affected by CPA, suggesting that the largely cGMP-dependent relaxation to SNP does not rely on SERCA. This suggests that the difference in the ability of HC aorta to relax to NO and SNP is related to impaired SERCA function. Moreover, after concomitant administration of ODQ and CPA, the difference in relaxation to NO between normal and HC aorta was eliminated. These data suggest that it is primarily the cGMP-independent relaxation to NO that relies on SERCA activity and that impairment of this mechanism accounts for the decreased response to NO in HC. Indeed, our data showing that SERCA-dependent 45Ca2+ uptake activity is reduced are compatible with this hypothesis.
Moreover, HC decreased the exponential half-time to decrease [Ca2+]i in primary cultured aortic smooth muscle cells. Aortic smooth muscle has 3 major [Ca2+]i extrusion mechanisms: SERCA, plasma membrane Ca2+ ATPase, and Na+/Ca2+ exchanger. We blocked the latter 2 mechanisms without causing any change in the decrease in [Ca2+]i caused by NO, whereas blocking SERCA drastically reduced the response.12 This suggests that a decrease in SERCA function in HC can explain the slower [Ca2+]i response to NO in HC rabbit aortic smooth muscle.
The molecular mechanisms by which NO increases calcium uptake by SERCA are not fully understood. Smooth muscle SERCA can be regulated by protein kinase G phosphorylating phospholamban, providing a cGMP-dependent mechanism to increase its activity.21 SERCA also was shown to be S-nitrosylated, providing a potential cGMP-independent mechanism of regulation by NO.23 This may explain why we found that the reductions in [Ca2+]i caused by both NO and SNP were both blocked by CPA but that ODQ blocked the reduction in [Ca2+]i caused by SNP but not NO. In contrast to the reduction in [Ca2+]i caused by SNP, relaxation caused by the NO donor was unaffected by blocking of SERCA, indicating that other mechanisms account for the relaxation. The most likely mechanism is the cGMP-dependent phosphorylation of myosin light chain phosphatase, which can account for relaxation without a decrease in [Ca2+]i.22 These data indicate that relaxation caused by NO and SNP differ substantially in their dependence both on a SERCA-mediated decrease in [Ca2+]i and on cGMP.
The small, insignificant decrease in SERCA expression can hardly account for the
50% decrease in SERCA-dependent 45Ca2+ uptake observed in HC. Decreased function of SERCA could be accounted for by abnormal function of the molecule itself or of molecules or substrates that regulate it. One possibility is that SERCA function is impaired by oxidative modification. Hydrogen peroxide or hypochlorous acid, both agents that are increased in HC, have been reported to inhibit SERCA function.24,25
HC increases superoxide generation that can inactivate NO.6 SOD or EUK-8, however, had no effect on NO-induced relaxation in HC aorta. This is compatible with previous data showing that adenovirus-mediated overexpression of SOD in the aorta of hypercholesterolemic rabbits had no effect on endothelium-dependent relaxation.8 These findings suggest that rapid removal of superoxide anion may not be enough to recover NO responsiveness in HC. This suggests that another mechanism, such as inactivation of SERCA, can explain the reduced NO response of smooth muscle in HC.
SNP is widely used as an endothelium-independent NO donor in studies of endothelial function because it is assumed to act similarly to NO itself. Our data suggest that NO and SNP rely on different mechanisms for relaxation. Whereas reduced SERCA function accounts for the impaired reduction in [Ca2+]i and relaxation to NO in HC, the relaxation to SNP remains normal because SERCA is not required for the cGMP-dependent relaxation caused by the NO donor. Whereas SNP is a good therapeutic agent, perhaps because it bypasses impaired SERCA function in diseased arteries, NO itself may be a better agent with which to judge whether or not the smooth muscle response to NO is normal in diseased arteries.
| Acknowledgments |
|---|
Received April 17, 2001; revision received May 3, 2001; accepted May 9, 2001.
| References |
|---|
|
|
|---|
2. Cohen RA. The role of nitric oxide and other endothelium-derived vasoactive substances in vascular disease. Prog Cardiovasc Dis. 1995; 38: 105128.[Medline] [Order article via Infotrieve]
3. Yaghoubi M, Oliver-Krasinski J, Cayatte AJ, et al. Decreased sensitivity to nitric oxide in the aorta of severely hypercholesterolemic apolipoprotein E deficient mice. J Cardiovasc Pharmacol. 2000; 36: 751757.[Medline] [Order article via Infotrieve]
4. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell. 1994; 78: 931936.[Medline] [Order article via Infotrieve]
5.
Harrison DG, Bates JN. The nitrovasodilators: new ideas about old drugs. Circulation. 1993; 87: 14611467.
6. Ohara Y, Peterson TE, Harrison DG. Hypercholesterolemia increases endothelial SO production. J Clin Invest. 1993; 91: 25462551.
7. Adachi T, Cohen RA. Decreased aortic glutathione levels may contribute to impaired nitric oxide-induced relaxation in hypercholesterolaemia. Br J Pharmacol. 2000; 129: 10141020.[Medline] [Order article via Infotrieve]
8.
Miller FJ Jr, Gutterman DD, Rios CD, et al. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998; 82: 12981305.
9.
Mugge A, Elwell JH, Peterson TE, et al. Chronic treatment with polyethylene-glycolated superoxide dismutase partially restores endothelium-dependent vascular relaxations in cholesterol-fed rabbits. Circ Res. 1991; 69: 12931300.
10.
Pagano PJ, Ito Y, Tornheim K, et al. An NADPH oxidase superoxide generating system in the rabbit aorta. Am J Physiol. 1995; 268: H2274H2280.
11. Weisbrod RM, Griswold MC, Yaghoubi M, et al. Evidence that additional mechanisms to cyclic GMP mediate the decrease in intracellular calcium and relaxation of rabbit aortic smooth muscle to nitric oxide. Br J Pharmacol. 1998; 125: 16951707.[Medline] [Order article via Infotrieve]
12.
Cohen RA, Weisbrod RM, Gericke M, et al. Mechanism of nitric oxideinduced vasodilatation: refilling of intracellular stores by sarcoplasmic reticulum Ca2+ ATPase and inhibition of store-operated Ca2+ influx. Circ Res. 1999; 84: 210219.
13.
Trepakova ES, Cohen RA, Bolotina VM. Nitric oxide inhibits capacitative cation influx in human platelets by promoting sarcoplasmic/endoplasmic reticulum Ca2+-ATPase-dependent refilling of Ca2+ stores. Circ Res. 1999; 84: 201209.
14. Bolotina VM, Najibi S, Palacino JJ, et al. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle cells. Nature. 1994; 368: 850853.[Medline] [Order article via Infotrieve]
15.
Najibi S, Cohen RA. Enhanced role of potassium channels in relaxation of hypercholesterolemic rabbit carotid artery to nitric oxide and sodium nitroprusside. Am J Physiol. 1995; 269: H805H811.
16.
Grover AK, Samson SE. Protection of Ca pump of coronary artery against inactivation by superoxide radical. Am J Physiol. 1989; 256: C666C673.
17. Schmidt K, Klatt P, Mayer B. Hypercholesterolemia is associated with a reduced response of smooth muscle guanylyl cyclase to nitrovasodilators. Arterioscler Thromb. 1993; 12: 11591163.
18.
Campbell DL, Stamler JS, Strauss HD. Redox modulation of L-type calcium channels in ferret ventricular myocytes. J Gen Physiol. 1996; 108: 277293.
19.
Archer SL, Huang JMC, Hampl V, et al. Nitric oxide and cGMP cause vasorelaxation by cGMP-kinase-dependent activation of a charybdotoxin-sensitive K channel. Proc Natl Acad Sci U S A. 1994; 91: 75837587.
20.
Komalavilas P, Lincoln TM. Phosphorylation of the inositol 1,4,5-trisphosphate receptor: cyclic GMP-dependent protein kinase mediates cAMP and cGMP dependent phosphorylation in the intact rat aorta. J Biol Chem. 1996; 271: 2193321938.
21. Cornwell TL, Pryzwansky KB, Wyatt TA, et al. Regulation of sarcoplasmic reticulum protein phosphorylation by localized cyclic GMP-dependent protein kinase in vascular smooth muscle cells. Mol Pharmacol. 1991; 40: 923931.[Abstract]
22.
Surks HK, Mochizuki N, Kasai Y, et al. Regulation of myosin phosphatase by a specific interaction with cGMP-dependent protein kinase 1
. Science. 1999; 286: 15831587.
23. Viner RI, Williams TD, Schoneich C. Nitric oxide-dependent modification of the sarcoplasmic reticulum Ca-ATPase: localization of cysteine target sites. Free Radic Biol Med. 2000; 29: 489496.[Medline] [Order article via Infotrieve]
24.
Xu KY, Zweier JL, Becker LC. Hydroxyl radical inhibits sarcoplasmic reticulum Ca2+ -ATPase function by direct attack on the ATP binding site. Circ Res. 1997; 80: 7681.
25.
Favero TG, Colter D, Hooper PF, et al. Hypochlorous acid inhibits Ca2+-ATPase from skeletal muscle sarcoplasmic reticulum. J Appl Physiol. 1998; 84: 425430.
This article has been cited by other articles:
![]() |
E. Perrier, M.-P. Fournet-Bourguignon, E. Royere, S. Molez, H. Reure, L. Lesage, W. Gosgnach, Y. Frapart, J.-L. Boucher, N. Villeneuve, et al. Effect of uncoupling endothelial nitric oxide synthase on calcium homeostasis in aged porcine endothelial cells Cardiovasc Res, April 1, 2009; 82(1): 133 - 142. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, H. Chai, P. H. Lin, Q. Yao, and C. Chen Roles and Mechanisms of Human Immunodeficiency Virus Protease Inhibitor Ritonavir and Other Anti-Human Immunodeficiency Virus Drugs in Endothelial Dysfunction of Porcine Pulmonary Arteries and Human Pulmonary Artery Endothelial Cells Am. J. Pathol., March 1, 2009; 174(3): 771 - 781. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Ying, X. Tong, D. R. Pimentel, R. M. Weisbrod, M. P. Trucillo, T. Adachi, and R. A. Cohen Cysteine-674 of the Sarco/Endoplasmic Reticulum Calcium ATPase Is Required for the Inhibition of Cell Migration by Nitric Oxide Arterioscler. Thromb. Vasc. Biol., April 1, 2007; 27(4): 783 - 790. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Laporte, A. Hui, and I. Laher Pharmacological Modulation of Sarcoplasmic Reticulum Function in Smooth Muscle Pharmacol. Rev., December 1, 2004; 56(4): 439 - 513. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. C. Resta Hypoxic regulation of nitric oxide signaling in vascular smooth muscle Am J Physiol Lung Cell Mol Physiol, August 1, 2003; 285(2): L293 - L295. [Full Text] [PDF] |
||||
![]() |
A. Revelli, D. Ghigo, F. Moffa, M. Massobrio, and I. Tur-Kaspa Guanylate Cyclase Activity and Sperm Function Endocr. Rev., August 1, 2002; 23(4): 484 - 494. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Adachi, R. Matsui, S. Xu, M. Kirber, H. L. Lazar, V. S. Sharov, C. Schoneich, and R. A. Cohen Antioxidant Improves Smooth Muscle Sarco/Endoplasmic Reticulum Ca2+-ATPase Function and Lowers Tyrosine Nitration in Hypercholesterolemia and Improves Nitric Oxide-Induced Relaxation Circ. Res., May 31, 2002; 90(10): 1114 - 1121. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |